Jyong Biotech Ltd. Ordinary Shares
MENS | NASDAQ
$1.89
+$0.01 (+0.53%)
Nov 2, 2026, 10:15 AM ET · Market open
Market Data
Market Cap $143.31M
Enterprise Value $160.3M
Beta 2.38
Average Volume 58.15K
Shares Outstanding (Diluted) 74.23M
Shares Change YoY 103626.11%
Institutional Ownership 0.67%
Exchange NASDAQ
ISIN KYG831161065
Price Performance
Price Change 1M -13.3%
Price Change 3M -5.5%
Price Change 6M -10.4%
Price Change YTD -52.1%
Price Change 1Y -95.6%
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) -8.7%
1Y CAGR (ann.) -96.2%
5Y CAGR (ann.) N/A
All-Time CAGR -70.7%
Valuation
PE Ratio -21.73
Forward PE N/A
PEG Ratio 0.45
Forward PEG 0.45
PS Ratio N/A
Forward PS N/A
PB Ratio -5.74
P/FCF Ratio N/A
P/Adj. FCF Ratio N/A
P/OCF Ratio N/A
EV/Sales N/A
EV/EBIT -61.02
EV/EBITDA -61.02
EV/FCF N/A
Earnings Yield -4.6%
FCF Yield 0.0%
Adj. FCF Yield 0.0%
Financial Health
Net Debt $17.35M
Total Debt $18.55M
Cash & Short-Term Investments $1.18M
Total Assets $20.78M
Current Ratio 0.45
Quick Ratio 0.45
Debt / Equity Ratio -0.74
Debt / EBITDA -7.06
Debt / FCF N/A
OCF / Debt 0.00
Interest Coverage -1.03
Altman Z-Score -2.20
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) N/A
Returns
Return on Assets -22.5%
Return on Equity 19.4%
Return on Invested Capital 46.0%
Return on Capital Employed 18.6%
Return on Tangible Assets -22.5%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y -5.7%
EPS CAGR 5Y 4.9%
EPS CAGR 10Y N/A
FCF CAGR 3Y -7.1%
FCF CAGR 5Y -7.7%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 12, 2026
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $0.00
Price Target Upside N/A
Cash Flow
Operating Cash Flow $0
Free Cash Flow $0
Adj. Free Cash Flow $0
FCF Per Share $0.00
OCF Per Share $0.00
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-2.61M
EBITDA $-2.63M
Net Income $-4.67M
EPS (Diluted) -$0.09
Revenue / Employee N/A
Profit / Employee $-173.06K
Employees 27
Add to Watchlist
Select watchlists to add or remove MENS